IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Indolent B-cell Lymphoma
Massachusetts General Hospitalmonoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Indolent B-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Linperlisib Shanghai YingLi Pharmaceutical Co. Ltd. | Phase 4 | BB |
Tazemetostat Shanghai YingLi Pharmaceutical Co. Ltd. | Phase 4 | BB |
Sofosbuvir Fondazione Italiana Linfomi - ETS | Phase 2 | B |
Velpatasvir Fondazione Italiana Linfomi - ETS | Phase 2 | B |
Ledipasvir Fondazione Italiana Linfomi - ETS | Phase 2 | B |
Di-B4 Cancer Research UK | Phase 1 | CC |
Tetrahydrouridine Yogen Saunthararajah | Early Phase 1 | CC |
Decitabine Yogen Saunthararajah | Early Phase 1 | CC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →